CELLA v. LILLY USA LLC

CourtDistrict Court, S.D. Indiana
DecidedFebruary 11, 2025
Docket1:24-cv-00814
StatusUnknown

This text of CELLA v. LILLY USA LLC (CELLA v. LILLY USA LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
CELLA v. LILLY USA LLC, (S.D. Ind. 2025).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF INDIANA INDIANAPOLIS DIVISION

DANIEL CELLA, ) ) Plaintiff, ) ) v. ) Case No. 1:24-cv-00814-TWP-MKK ) LILLY USA LLC, ) THE LILLY SEVERANCE PAYMENT PLAN, ) THE LILLY SEVERANCE PAY PLAN, ) ) Defendants. )

ORDER GRANTING DEFENDANTS' MOTION TO DISMISS COUNT II OF PLAINTIFF'S SECOND AMENDED COMPLAINT This matter is before the Court on Defendants Lilly USA LLC, The Lilly Severance Payment Plan, and the Lilly Severance Pay Plan's (collectively, "Lilly") Motion to Dismiss Count II of the Plaintiff's Second Amended Complaint ("the Complaint"). (Filing No. 23.) After his discharge in August 2022, Daniel Cella ("Cella") initiated this action to recover severance benefits from the Lilly Severance Pay Plan ("the Plan") under Section 502(a) of the Employee Retirement Income Security Act ("ERISA"), 29 U.S.C. § 1132(a). (See Filing No. 21 at 7.) Cella further alleged that Lilly unlawfully interfered with the attainment of his severance benefits in violation of ERISA § 510, 29 U.S.C. § 1140. Id. at 8. Lilly now moves to dismiss Count II of the Second Amended Complaint, the § 510 claim, for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6). Lilly's motion is granted. I. BACKGROUND The Court accepts the following facts as true and considers them in a light most favorable to Cella, as the Court must when considering a Rule 12(b)(6) motion. Bielanski v. Cnty. Of Kane, 550 F.3d 632, 633 (7th Cir. 2008). A. Factual Background Cella began his employment with Lilly as a Sales Representative in July 2000 and remained with the company until his termination in August 2022. (Filing No. 21 ¶ 7.) During those twenty- two years, Cella maintained a clean disciplinary record and was promoted at least twice: once in

2021 to Thought Leader Liaison, and again in 2022 to Senior Director in Lilly's dermatology department. See id. ¶¶ 15, 30, 40. In October 2021, Cella and the "Centralized Congress Team" began planning for a weekend-long dermatology conference scheduled for March 2022. Id. ¶ 15. With five months left until the conference began, the Centralized Congress Team encouraged employees to book their own hotel rooms at the Boston Renaissance Hotel while space was still available. Id. ¶ 16. Cella obliged and used Lilly's travel booking system, Concur, to reserve his room. Id. ¶ 17. One month before the conference, Cella received an external email with a link to register for the conference and to book a hotel room. Id. ¶ 19. Having forgotten that he had already booked a room at the Boston Renaissance Hotel, he used the link to reserve a second room at another hotel,

the Boston Park Plaza where he ultimately stayed. Id. ¶¶ 20–23. On March 26, 2022, Cella gathered for a meal with colleagues at the Boston Renaissance Hotel. Id. ¶ 24. After the conference events concluded for that day, Cella returned to the Boston Park Plaza. Id. ¶ 25. When he returned to work to account for his conference expenses in Concur, he observed a $406.00 charge from the Boston Renaissance Hotel dated March 26, 2022. Id. ¶ 28. He assumed the charge reflected the tab from his outing with colleagues and submitted it as a "business meal." Id. ¶ 29. In the months that followed, noticing discrepancies, two Lilly human resources representatives, Kristina Hartman ("Hartman") and Eric McCray ("McCray"), sought to investigate Cella's conference expenses. Id. ¶ 31–34. In a meeting with Cella on August 3, 2022, McCray explained that the March expense reflected a "no-show" charge from the Boston Renaissance Hotel that he had classified as a business meal expense. Id. ¶ 33. Cella responded that this was "an unintentional mistake" and apologized for the "inadvertent error." Id. ¶¶ 33–34. McCray further

questioned Cella about a separate March 26, 2022, expense submitted by another employee who listed Cella as an attendee at a business meal that day. Id. ¶ 35. Cella maintained that he did not attend that meal and did not know why the employee included him as a participant. Id. ¶ 36. Nevertheless, in a second HR meeting on August 4, 2022, McCray and Hartman terminated Cella for a "pattern of behavior inconsistent with the Company's core values." Id. ¶ 38. In due course, Cella applied for severance benefits under the Lilly Severance Pay Plan. See id. ¶ 41. As a Lilly employee, he was entitled to benefits under the Plan unless, among other things, he was terminated for "misconduct, including, but not limited to, dishonesty, [or] falsification of reports." (Filing No. 19-1 at 21.) The Employee Benefits Committee denied his claim. (Filing No. 21 ¶ 41.) He appealed that decision and was again denied. Id. ¶¶ 42–43.

B. Procedural Background Cella sued Lilly and the Plan to recover his benefits under the Plan pursuant to ERISA § 502(a). He also alleged that Lilly unlawfully interfered with his ability to obtain his benefits under the Plan in violation of ERISA § 510. He filed the original complaint on May 14, 2024. (Filing No. 1.) Cella filed First and Second Amended Complaints on June 6, 2024 (Filing No. 9), and July 15, 2024 (Filing No. 21), respectively. The Second Amended Complaint lists the following claims: Count I: Denial of Benefits (the Plan) and Count II: Interference with Benefits (Lilly). Id. at 7-8. Lilly moved to dismiss the unlawful interference claim in the Second Amended Complaint on July 29, 2024. (Filing No. 23.) Thereafter, Cella moved for leave to file a Third Amended Complaint. (Filing No. 49.) The Magistrate Judge denied Cella's request (Filing No. 59). On December 17, 2024, the Court heard argument on the Motion to Dismiss (see Filing No. 60), which is before the Court for ruling. II. LEGAL STANDARD

"To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to state a claim to relief that is plausible on its face." Yeftich v. Navistar, Inc., No. 09-cv-1045, 2010 WL 3893851, at *2, (S.D. Ind. Sept. 28, 2010) (quoting Ashcroft v. Iqbal, 566 U.S. 662, 678 (2009)) (internal quotation marks omitted). "A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged." Iqbal, 556 U.S. at 678. The complaint need not "match[] facts to legal elements," Thomas v. JBS Green Bay, Inc., 120 F.4th 1335, 1337 (7th Cir. 2024), but "[t]hreadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice to withstand the requirements of Federal Rules of Civil Procedure 8 and 12(b)(6)," Yeftich, 2010 WL 3893851, at *2 (citation and internal quotation marks omitted). In

addressing a Rule 12(b)(6) motion, the Court treats all well-pleaded factual allegations as true and construes all reasonable inferences in favor of Cella as the non-movant. Yeftich, 2010 WL 3893851, at *2. III. DISCUSSION In Count II, Cella asserts a claim against Lilly USA for interference with benefits pursuant to ERISA § 510, 29 U.S.C. § 1140.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

William M. Salus v. Gte Directories Service Corp.
104 F.3d 131 (Seventh Circuit, 1997)
Reichle v. Howards
132 S. Ct. 2088 (Supreme Court, 2012)
Bielanski v. County of Kane
550 F.3d 632 (Seventh Circuit, 2008)
Brooks v. Ross
578 F.3d 574 (Seventh Circuit, 2009)
Lee v. Ne. Ill. Reg'l Commuter R.R. Corp.
912 F.3d 1049 (Seventh Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
CELLA v. LILLY USA LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cella-v-lilly-usa-llc-insd-2025.